Analyst Upgrades

• Marriott (MAR) to outperform from market perform at Wells Fargo.
• Quest Diagnostics (DGX) and Owens-Illinois (OI) to outperform from neutral at Credit Suisse.
• FirstMerit (FMER) to outperform from perform at Oppenheimer.
• Safeway (SWY) to hold from sell at Citigroup.
• Babcock & Wilcox (BWC) to buy from neutral, as well as Jacobs Engineering (JEC) and W. R. Berkley (WRB) to neutral from sell, at Goldman.
• Pioneer Natural (PXD) to overweight from equal weight at Barclays.
• Teekay Tankers (TNK) to buy from underperform at BofA/Merrill.

As I wrote in this article, there's no way you should be buying Apple Inc. (NASDAQ: AAPL) stock right now. Yes, it could break out to new highs, but until it actually does, it's just a triple-top chart pattern and considering we're talking about a measly 7% gain from here to the break-out level, just wait until it breaches $203 and does so convincingly. After all, if it's meant to fulfill the $300 prophecy as foretold by the oracles (aka market cheerleaders), you'll still have plenty of room to profit, just without all the risk. Yup, even with fundamentally sound companies, it's crucial that you consider technical analysis to your investments, as Google Inc. (NASDAQ: GOOG) shareholders learned the hard way after its perfect triple-top back above $700 (a top I called to short based on -- what else? -- technical analysis!).

Even though those are the stocks about which I get most email, they aren't the ones I want to write about today -- because the stocks I like are the ones I talk about in my new internet TV show LiveStock:



(Contact me with any stock market questions you'd like answered on live broadcasts every Friday from 1-2PM which you can view HERE) have been influenced by some kind of temporary catalyst, whether it's an analyst or newsletter recommendation, message board hype, or stock promoter spam. After that's gone, all you have left are struggling small-cap companies looking to raise capital. It's ugly.